Skip to main content

Table 2 Characteristics of studies included in this review

From: Lymphadenectomy after a positive sentinel node biopsy in patients with cutaneous melanoma. A systematic review

Author

Median Age (years)

Gender

Tumor location

Breslow Thickness (mm)

Ulceration %

1 positive SLN

SLN metastasis

≤ 1 mm

year

Obs.

CLND

Female

Male

Extremity

Head & neck

Trunk

Obs.

CLND

Obs.

CLND

Obs.

CLND

Bamboat (Bamboat et al., 2014)

66 (8–95)

56 (7–90)

185 (37%)

310 (63%)

231 (47%)

58 (12%)

182 (37%)

2.8

218/446 (49%)

380 (77%)

230 (46%)

2.8 (0.7–18)

2.8(0.7–38)

77 (46%)

141 (44%)

134 (80%)

246 (75%)

Satzger (Satzger et al., 2014)

64 (10–91)

60 (18–87)

141 (46%)

164 (54%)

154(50%)

21(7%)

130 (43%)

 

122 (40%)

243 (80%)

 

2.3 (1.0–13)

2.6 (1.0–17)

22 (38%)

100 (40%)

51 (88%)

192 (78%)

Ploeg (van der Ploeg et al., 2014)

52.3 ± 15.3b

702(46%)

837(54%)

779(51%)

211(14%)

533(35%)

2.95 (1.80–4.50)

655/1436 (46%)

1030 (79%)

811(53%)

Melstrom (Melstrom et al., 2014)

55 (19–89)

25 (26%)

72 (74%)

16 (17%)

13 (13%)

68 (70%)

3.2 (0.8–12)

49 (51%)

  

58 (19–89)

53 (24–77)

4.2(1.2–10.5)

3 (0.8–12)

7(33%)

42 (55%)

Gyorki (Gyorki et al., 2014)

66

54

14 (26%)

40 (74%)

0

54 (100%)

0

2.2 (0.9–18.0)

2.8 (1.1–15.0)

20 (37%)

  

8 (44%)

12 (33%)

Fritsch (Fritsch et al., 2016)

58 (3–89)

71 (20%)

66

0

350 (100%)

0

 

106 /327 (32%)

  

62 (3–89)

54 (11–87)

41 (32%)

65 (33%)

Mosquera (Mosquera et al., 2017)

56

843 (39%)

1329 (61%)

1051 (48%)

281 (13%)

840 (39%)

 

783/2131 (36%)

1586 (73%)

 

59 (10–98)

55 (2–91)

34% (263)

66% (520)

590 (83%)

996 (69%)

Lee (Lee et al., 2016)

56 (7–95)a

53 (4–98)a

187 (40%)

284 (60%)

201 (43%)

76 (16%)

194 (41%)

3.1 ± 2.7 b

3.0 ± 3.6 b

135/456 (30%)

377 (80%)

 

34 (35%)

101 (27%)

79 (82%)

298 (80%)

Faries (Faries et al., 2017)

54.9 (19–76)

53.7 (18–76)

728 (41%)

1027 (59%)

709 (40%)

241 (14%)

805 (46%)

2.10 (0.35–30.0)

2.10 (0.34–28.0)

669 (38%)

1239/1564 (79%)

786/1189 (66%)

353 (38%)

316 (38%)

643 (69%)

596 (72%)

Klemen (Klemen et al., 2019)

54.5 (42.4–66.7)a

376 (39%)

577 (61%)

428 (45%)

126 (13%)

397 (42%)

2.5 (1.4–4.1)a

120 /588 (13%)

  

64 (51–75)a

53.6 (41.6–65.1)a

2.4 (1.4–4.5)a

2.5 (1.4–4)a

13 (11%)

107 (13%)

Leiter (Leiter et al., 2019)

54 (45–66.5)a

182 (38%)

291 (62%)

226 (48%)

0

247 (52%)

2.4 (1.6–4)a

185 (39%)

435 (92%)

311(66%)

56 (45–66)a

57 (47–67.8)a

2.4 (1.5–3.85)a

2.4 (1.6–4)a

95 (41%)

90 (38%)

213 (91%)

222 (91%)

  1. Obs Observation, RCT Randomized Clinical Trial
  2. Values are median (Range) unless otherwise are indicated. a Median (Interquartilare Range). b Mean (Estándar desviation)